{"id":16773,"date":"2014-03-07T09:32:44","date_gmt":"2014-03-07T14:32:44","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=16773"},"modified":"2014-03-07T09:32:44","modified_gmt":"2014-03-07T14:32:44","slug":"rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773","title":{"rendered":"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss"},"content":{"rendered":"<p>Boston, MA 03\/07\/2014 (wallstreetpr) &#8211; <b>Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) <\/b>was the subject of a surge in the market after registering a narrower loss for its fourth quarter. Immediately after the announcement the company\u2019s shares surged by a high of 10.8%.<\/p>\n<p>Rigel Pharmaceuticals saw its fourth quarter net loss clock in at 19 cents per share against Zacks consensus estimates of 24 cents. This was a massive improvement considering the company registered a net loss of 30 cents for the same quarter a year ago.<\/p>\n<p><b>Rigel Pharmaceuticals Revenue<\/b><\/p>\n<p>Rigel Pharmaceuticals generated total revenues amounting to $5.8 million for the fourth quarter that toppled Zacks consensus estimates of $2 million, total revenues was made solely of contract revenues<\/p>\n<p><b>Rigel Pharmaceuticals expenses<\/b><\/p>\n<p>Research and development expenses came in at $18 million for the fourth quarter a drop of 8.7% compared to the same quarter a year ago. The drop in the research and development expenses was mainly as a result of the completion of phase II study of asthma pill R343. Stock based and bonus compensation expenses dropped, in the quarter. General and administrative expenses for the quarter came in at $4.6 million a drop of 20.6% compared to the same quarter a year ago.<\/p>\n<p>Rigel Pharmaceuticals has also announced plans to restart the development of fostamatinib a pill used for treating patients suffering from immune thrombocytopenic condition.<\/p>\n<p><b>Full year results<\/b><\/p>\n<p>Rigel Pharmaceuticals full year net loss beat consensus estimates coming in at $1 per share against set estimates of $1.05 per share. This was slightly lower compared to a net loss of $1.32 reported in F2012. Full year revenues also beat consensus estimates of $3 million coming in at $7.2 million<\/p>\n<p>Rigel Pharmaceuticals is currently rated as a \u201cBuy\u201d by research analysts at Jefferies Group with a share price target of $10.<\/p>\n<p><b>Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)<\/b> surged further in Thursday trading session moving up by $10.24% to close the day at a high of $4.52<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 03\/07\/2014 (wallstreetpr) &#8211; Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) was the subject of a surge in the market after registering a narrower loss for its [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":16800,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2477,2476],"stock_ticker":[],"class_list":["post-16773","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqrigl","tag-rigel-pharmaceuticals-inc-nasdaqrigl","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 03\/07\/2014 (wallstreetpr) &#8211; Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) was the subject of a surge in the market after registering a narrower loss for its [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-03-07T14:32:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss\",\"datePublished\":\"2014-03-07T14:32:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\"},\"wordCount\":318,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg\",\"keywords\":[\"NASDAQ:RIGL\",\"Rigel Pharmaceuticals Inc. (NASDAQ:RIGL)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\",\"name\":\"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg\",\"datePublished\":\"2014-03-07T14:32:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg\",\"width\":1024,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773","og_locale":"en_US","og_type":"article","og_title":"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss - Wall Street PR","og_description":"Boston, MA 03\/07\/2014 (wallstreetpr) &#8211; Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) was the subject of a surge in the market after registering a narrower loss for its [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-03-07T14:32:44+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss","datePublished":"2014-03-07T14:32:44+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773"},"wordCount":318,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg","keywords":["NASDAQ:RIGL","Rigel Pharmaceuticals Inc. (NASDAQ:RIGL)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773","url":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773","name":"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg","datePublished":"2014-03-07T14:32:44+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/index6.jpg","width":1024,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/rigel-pharmaceuticals-inc-nasdaqrigl-surges-on-narrower-fourth-quarter-loss-16773#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges on Narrower Fourth Quarter Loss"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/16773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=16773"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/16773\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/16800"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=16773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=16773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=16773"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=16773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}